Diplomat Pharmacy, Inc. (DPLO) financial statements (2020 and earlier)

Company profile

Business Address 4100 S. SAGINAW ST.
FLINT, MI 48507
State of Incorp. MI
Fiscal Year End December 31
SIC 5912 - Drug Stores and Proprietary Stores (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments898482818
Cash and cash equivalents898482818
Receivables338327332276255158
Inventory, net of allowances, customer advances and progress billings181211207215166111
Inventory181211207215166111
Deferred tax assets  1552
Other undisclosed current assets141011672
Total current assets:542556634520461291
Noncurrent Assets
Operating lease, right-of-use asset27
Property, plant and equipment283539201713
Long-term investments and receivables   054
Long-term investments   054
Intangible assets, net (including goodwill)5278501,22551648168
Goodwill37261083331725623
Intangible assets, net (excluding goodwill)15624139220022545
Regulated entity, other noncurrent assets1315    
Deferred costs    51
Other noncurrent assets556101
Other undisclosed noncurrent assets201637503712
Total noncurrent assets:6209201,30658854599
TOTAL ASSETS:1,1631,4761,9401,1081,006390
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities410342444339313209
Accounts payable368308413321297202
Accrued liabilities28212112114
Employee-related liabilities131310662
Debt553121286 
Business combination, contingent consideration, liability658 536
Other undisclosed current liabilities2320018839  
Total current liabilities:992559651385372215
Noncurrent Liabilities
Long-term debt and lease obligation24438521100111 
Long-term debt, excluding current maturities 438521100111 
Operating lease, liability24
Liabilities, other than long-term debt16918971
Deferred tax liabilities, net314971
Deferred income tax liabilities1
Other liabilities 0   0
Business combination, contingent consideration, liability524   
Derivative instruments and hedges, liabilities104    
Other undisclosed noncurrent liabilities 5   5
Total noncurrent liabilities:404535391091186
Total liabilities:1,0321,0111,191494490221
Stockholders' equity
Stockholders' equity attributable to parent, including:131465750613512164
Common stock642629619504452 
Additional paid in capital565138332910
Accumulated other comprehensive loss(10)(4)    
Retained earnings (accumulated deficit)(556)(211)9276315
Other undisclosed stockholders' equity attributable to parent     149
Stockholders' equity attributable to noncontrolling interest   045
Total stockholders' equity:131465750614516169
TOTAL LIABILITIES AND EQUITY:1,1631,4761,9401,1081,006390

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues5,2065,4934,4854,4103,3672,215
Revenue, net4,4854,4103,3672,215
Cost of revenue
(Cost of Goods and Services Sold)
(4,897)(5,117)(4,137)(4,086)(3,103)(2,087)
Other undisclosed gross profit     12
Gross profit:309376349325263140
Operating expenses(923)(643)(330)(278)(217)(136)
Other undisclosed operating income     8
Operating income (loss):(614)(267)19474613
Nonoperating expense(42)(40)(11)(11)(5)(3)
Other nonoperating income120001
Interest and debt expense(43)(42)(11)(7)(5)(3)
Income (loss) from continuing operations before equity method investments, income taxes:(699)(349)(3)30367
Loss from equity method investments     (6)
Other undisclosed income from continuing operations before income taxes434211759
Income (loss) from continuing operations before income taxes:(656)(307)836419
Income tax expense (benefit)757(11)(16)5
Income (loss) before gain (loss) on sale of properties:(649)(302)15252514
Other undisclosed net loss     (9)
Net income (loss):(649)(302)1525255
Net income attributable to noncontrolling interest  0310
Net income (loss) attributable to parent:(649)(302)1628265
Preferred stock dividends and other adjustments     9
Other undisclosed net loss available to common stockholders, basic     (10)
Net income (loss) available to common stockholders, diluted:(649)(302)1628264

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(649)(302)1525255
Comprehensive income (loss):(649)(302)1525255
Comprehensive income, net of tax, attributable to noncontrolling interest  0310
Other undisclosed comprehensive loss, net of tax, attributable to parent(10)(4)    
Comprehensive income (loss), net of tax, attributable to parent:(659)(307)1628265

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: